HB Wealth Management LLC Purchases 27,192 Shares of Haleon PLC Sponsored ADR (NYSE:HLN)

Key Points

• HB Wealth Management LLC increased its stake in Haleon PLC by 42.2% in the first quarter, owning 91,594 shares valued at $943,000.
• Several institutional investors have also made significant changes to their positions in Haleon, including Wellington Management Group LLP, which grew its stake by 67.5%.
• Despite recent upgrades from analysts, Haleon's stock has decreased by 1.6%, trading at $9.65 with a market cap of $43.35 billion.

HB Wealth Management LLC increased its position in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 42.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 91,594 shares of the company's stock after acquiring an additional 27,192 shares during the period. HB Wealth Management LLC's holdings in Haleon were worth $943,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in HLN. Allspring Global Investments Holdings LLC grew its stake in shares of Haleon by 6.1% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 30,223 shares of the company's stock valued at $306,000 after purchasing an additional 1,749 shares during the period. Oppenheimer & Co. Inc. grew its position in Haleon by 11.2% during the first quarter. Oppenheimer & Co. Inc. now owns 25,362 shares of the company's stock valued at $261,000 after buying an additional 2,564 shares during the period. Concurrent Investment Advisors LLC increased its holdings in Haleon by 32.9% during the first quarter. Concurrent Investment Advisors LLC now owns 16,363 shares of the company's stock valued at $168,000 after buying an additional 4,055 shares during the last quarter. Mather Group LLC. raised its position in Haleon by 60.7% in the first quarter. Mather Group LLC. now owns 9,036 shares of the company's stock worth $93,000 after acquiring an additional 3,413 shares during the period. Finally, Farther Finance Advisors LLC boosted its stake in shares of Haleon by 8.8% during the 1st quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company's stock worth $131,000 after acquiring an additional 1,041 shares during the last quarter. 6.67% of the stock is owned by institutional investors.

Analyst Ratings Changes

HLN has been the subject of several analyst reports. Barclays restated an "overweight" rating on shares of Haleon in a research note on Tuesday, May 6th. BNP Paribas Exane upgraded Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target for the company in a research report on Tuesday, May 27th. Morgan Stanley raised Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price objective on the stock in a research report on Friday, May 9th. Wall Street Zen lowered shares of Haleon from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Finally, BNP Paribas upgraded shares of Haleon to a "strong-buy" rating in a research note on Tuesday, May 27th. Six investment analysts have rated the stock with a hold rating, four have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $12.33.

Haleon Price Performance

Shares of NYSE:HLN traded up $0.24 during trading on Friday, hitting $9.67. 16,930,452 shares of the company's stock were exchanged, compared to its average volume of 11,525,428. The business's 50-day simple moving average is $10.37 and its 200 day simple moving average is $10.18. The company has a market cap of $43.44 billion, a price-to-earnings ratio of 24.80, a PEG ratio of 2.73 and a beta of 0.23. Haleon PLC Sponsored ADR has a 52-week low of $8.86 and a 52-week high of $11.42. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.98 and a quick ratio of 0.78.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.